Obesity, particularly central adiposity, is a well-established risk factor for cardiovascular disease (CVD). Waist circumference (WC) is measured in numerous epidemiologic studies as a relatively simple indicator of central adiposity. However, recently, investigators have considered a measure that takes height into consideration, waist-to-height ratio (WHtR) as a more sensitive predictor of CVD. A limited number of studies have examined the association between various measures of central adiposity and obesity with CVD, but there is a dearth of information on this topic focused specifically on African American adults. Given the high rates of cardiovascular disease and metabolic risk factors in this population, it is important to develop validated, easy-tomeasure indicators of CVD risk for clinical use. Data from 4758 African American adults participating in the baseline visit of the Jackson Heart Study with available risk factor data were examined, with three measures of body habitus (body mass index (BMI), WC, and WHtR) and five CVD risk factors (HDL and LDL cholesterol, triglycerides, diabetes, and hypertension), the latter also categorized into multiple (2+) risk factors present. C-statistics for waist circumference (WC), BMI, and WHtR were computed and compared for each model to assess their discriminant abilities. WHtR was a stronger correlate of HDL cholesterol, triglycerides, diabetes, hypertension, and multiple risk factors compared to BMI, and was a stronger correlate of HDL cholesterol when compared to WC. These data indicate that, for African American adults, WHtR may be more appropriate measure to identify those at elevated risk for CVD.
Introduction
Obesity is a well-established risk factor for cardiovascular diseases (CVD) [1] . Evidence suggests that centrally located body fat may be a more important contributor to CVD risk than measures that do not take central adiposity, such as body mass index (BMI), into consideration [2, 3] . Waist circumference (WC) and its corollary, waist-to-hip ratio, are used in epidemiologic studies as relatively simple to measure indicators of central adiposity and have been shown to be more reflective of overall adiposity relative to other measures [4] . However, recently, investigators have considered a measure that takes height into consideration (waist-to-height ratio, WHtR) as a more sensitive predictor of CVD [5] [6] [7] [8] [9] [10] [11] [12] . A 2008 report from the World Health Organization (WHO) provided a summary of research to date on WC and WHtR as indicators of chronic disease risk. This report indicated the need to consider age, sex, and race/ethnic differences in measures of central adiposity [13] .
Among those studies that have examined the predictability of measures of central adiposity on CVD risk, specifically WHtR, few have focused specifically on African American adults. The WHO report [12] did not have reference to this population. Given the high rates of CVD and metabolic risk factors for CVD in this population [1] , it is important to develop validated, easy-to-measure indicators of CVD risk for clinical use. This analysis used data from a large epidemiologic study of CVD in African Americans to compare the predictive ability of three measures of adiposity, BMI, WC, and WHtR for assessing CVD risk. We used baseline data and compared the associations of these composition measures to traditional CVD risk factors and composites of these indicators by each of these body habitus measures using logistic regression and c-statistics. We hypothesized that WHtR will be more strongly related to CVD risk factors among African Americans relative to the other body habitus measures.
Methods

Overview
The Jackson Heart Study (JHS) has been described in detail elsewhere [14, 15] . Briefly, the JHS is the largest longitudinal epidemiologic study of CVD in African Americans. The JHS enrolled 5306 participants aged 21-84 years at the time of the baseline assessment (2000) (2001) (2002) (2003) (2004) fromtheJackson,Mississippi,metropolitan area (Hinds, Madison, and Rankin counties). Participants were recruited from four different sources: (1) previous participants in the Atherosclerosis Risk in Communities study (30% of JHS cohort), (2) family members of JHS participants (28%), (3) random selection from the three counties (17%), and (4) community volunteers (25%). The goal of the JHS was to examine factors that influence the development of CVD in African American men and women to learn how to prevent this group of diseases in this population. JHS participants provided information on demographic, socioeconomic, and lifestyle variables, as well as medication use. Certified technicians and nurses conducted clinic interviews. Two subsequent in-person follow-up visits have been completed since baseline (2005-2008 and 2009-2013) . Data for this analysis come from the baseline visit, with the analysis limited to the 4758 participants with data for all the variables considered.
Dependent Variables
Blood samples were collected using standard procedures and analyzed at a central laboratory (University of Minnesota) [16] . Fasting glucose and lipids were measured on a Vitros 950 or 250, Ortho-Clinical Diagnostics analyzer (Raritan, NJ), in accordance with the College of American Pathologists Proficiency Testing Program (Carpenter) . Type 2 diabetes status was defined according to the 2010 American Diabetes Association guidelines: (1) physician diagnosis, (2) use of diabetes medication, (3) fasting glucose ≥ 126 mg/dL, or (4) A1C ≥ 6.5% [17] . Blood pressure was measured using the Omron HEM907XL automated BP monitor. Two resting systolic and diastolic blood pressures were measured at 5-min intervals and the average was used for the current analysis.
CVD risk factors were considered as continuous variables and were categorized along clinically relevant thresholds. Triglycerides were dichotomized into a low group consisting of < 150 mg/dL and a high group. LDL cholesterol was dichotomized into a low group consisting of < 160 mg/dL and a high group. HDL cholesterol was dichotomized using sexspecific values with a low group consisting of males with HDL cholesterol ≤ 35 mg/dL or females with an HDL ≤ 45 mg/dL and a high group. Diabetes was defined as current use of insulin or oral antidiabetic agent, fasting glucose ≥ 126 mg/dL, or HbA1C ≥ 6.5%. Hypertension was defined as having a systolic blood pressure of ≥ 140 mmHg or a diastolic blood pressure ≥ 90 or a self-reported prescription of blood pressure medications. CVD risk factors were defined as having low HDL, high LDL, high triglycerides, diabetes, and hypertension. These risk factors were summed into a risk count score. Risk count score was dichotomized into < 2 risk factors and greater.
Independent Variables
Weight was measured to the nearest 0.1 kg and height to the nearest centimeter. BMI was calculated as weight divided by the square of the height. WC was measured to the nearest centimeter as the average of two readings at the umbilicus with the patient upright. WC was dichotomized based on the National Cholesterol Education Program Adult Treatment Panel III cutoff points as ≤ 102 or > 102 cm for men, and ≤ 88 or > 88 cm for women. BMI was categorized into Underweight, Normal, Overweight, and Obese categories corresponding to BMI levels of < 18.5, 18.5 to 25, 25 to < 30, and ≥ 30 kg/m 2 . Underweight and normal weight were combined in the analyses since the number of underweight participants was relatively small. As has been used in other studies [6] , WHtR was calculated as waist/height and was dichotomized into ≤ 0.5 and greater. All three measures were also considered as continuous variables.
Statistical Analysis
General linear models were used to examine the association between demographic and health characteristics and each of the three body habitus measures. Logistic regression analyses were performed to examine the correlation of WC, BMI, and WHtR with known CVD risk factors, including low HDL, high LDL, high triglycerides, diabetes status, and hypertension status. For each CVD risk factor, three separate logistic regression models were fit using WC, BMI, or WHtR as a predictor while adjusting for age and gender. C-statistics for WC, BMI, and WHtR were computed and compared based on U-statistics theory for each risk factor to assess their discriminant abilities [18] . Similar analyses were conducted for the dichotomized risk score. All analyses were performed on SAS v9.4 (SAS Inc., Cary, NC). Table 1 displays demographic and health characteristics of the study population at the baseline visit stratified by gender. The mean age of the sample was approximately 55 years, with the majority being in the 45-64 year age range. Approximately 15-20% had high triglycerides and high LDL cholesterol. More women had low HDL cholesterol compared to men (27.0 vs. 17.5%). Diabetes was slightly more prevalent among women compared to men (19.4 vs. 17.0%), as well as hypertension (61.6 vs. 57.3%). Men and women had on average one risk factor, and about 36% of men and 41% of women had at least two risk factors present.
Results
With regard to body habitus measures, the mean WC and mean BMI for men and women were 101.3 and 100.4 cm, and 29.9 and 32.8 kg/m 2 , respectively. Women were far more likely than men to have a higher WC (75.1 vs. 40.4%). Similarly, far more women than men were classified as obese (59.9 vs. 40.5%). The mean WHtR was similar for men and women (0.6), but slightly more women than men had a WHtR above the recommended cutoff point level (86.8 vs. 81.4%). Table 2 shows the distribution of the selected demographic characteristics according to the categories of BMI, WC, and WHtR. The proportion of female participants increased from low-to high-risk categories. For BMI, the overweight group has the highest mean age, and for the WC and WHtR, participants in the highest-risk categories were older. In general, across the health characteristics, the high-risk body habitus categories corresponded with higher CVD risk, and the proportion of participants with 2+ CVD risk factors was highest in the highest-risk body habitus categories for all measures. Table 3 displays relationships between the three body habitus measures using continuous values and the selected demographic and health characteristics. BMI was significantly higher for those that were female, younger, and those that had low HDL cholesterol, diabetes, hypertension, and multiple risk factors compared to their counterparts. WC was significantly higher for those that were older, and those that had low HDL cholesterol, diabetes, hypertension, and multiple risk factors compared to their counterparts. WHtR was significantly higher for those that were female and older, and those that had low HDL cholesterol, diabetes, hypertension, and multiple risk factors compared to their counterparts. Table 4 shows age-and sex-adjusted c-statistic differences between WHtR and BMI values, and between WHtR and WC values, for each of the five CVD risk factors individually, and for the dichotomous compilation of risk factors (< 2, ≥ 2). For the comparison between WHtR and BMI, the c-statistic value was significantly higher (p < 0.0001) between triglycerides, diabetes, and hypertension, and having ≥ 2 risk factors. For the comparison between WHtR and WC, the WHtR c-statistic was similar between the two measures for most risk factors and was significantly greater only for HDL cholesterol.
Discussion
CVD is a major public health issue, and African Americans are disproportionately impacted by this condition [1] . Obesity is a well-recognized risk factor for CVD [1] . Thus, tools are needed to adequately identify African Americans at increased risk for CVD in the clinical setting. Traditionally, BMI has been used as a surrogate for more invasive measures of body composition and obesity status, but concerns have been raised that this measure does not accurately take into consideration central adiposity, which in and of itself is a risk factor for CVD, leading for a call to validate measures such as WC and WHtR to be used to assess CVD risk [13] .
In this analysis, we examined the associations of three measures of body habitus, BMI, WC, and WHtR with traditional CVD risk factors in a large, well-characterized sample of African American adults. We found that WHtR was more strongly related to CVD risk than BMI, was similar to WC in terms of most CVD risk factors, and was more strongly related to HDL cholesterol compared to both BMI and WC. Our findings add to a fairly large body of literature on this topic and are similar to those of other studies on this topic [5] [6] [7] [8] [9] [10] [11] [12] . In their systematic review, Browning and colleagues found that the majority of studies in their review favored WHtR and WC as stronger predictors of cardiometabolic risk compared to BMI, with c-statistic values of 0.704, 0.693, and 0.671, respectively. The studies in their analysis included populations of Caucasian, Asian, and Central American descent and affirmed the 0.5 cutoff for WHtR as the optimal level of assessing CVD and diabetes risk [19] . It is also worth noting that in their cross-sectional analyses examining associations between CVD risk factors and obesity indices, Sex (%) Female 378 (54.6%)* similar to our design, most of the studies in this systematic review adjusted for BMI in the WC and WHtR logistic models. The meta-analysis by Ashwell and colleagues [6] , including more than 300,000 adults across several ethnic groups, also affirmed the stronger association between WHtR and cardiometabolic risk relative to other measures of body habitus. There is some evidence that the relationship between measures of adiposity and CVD risk differs between Whites and African Americans. Katzmarzyk and colleagues [20] found that BMI, body adiposity index, WC, WHtR, and waist-to-hip ratio were also significantly and positively associated with all-cause mortality in Whites, but WC was the only indicator that significantly predictedmortalityinAfricanAmericans.However,a recentstudy by Kazlauskaite and colleagues showed that WHtR is similarly effective as a CVD risk screening tool for midlife Hispanic, Chinese, Japanese, White, and African American women [21] . Thus, our study adds the body of literature on measures of body habitus and CVD risk in African American adults.
This study has a number of strengths that should be acknowledged. First, we analyzed data from a large, population-based study of African American adults, a population at significant risk for CVD. Second, this is, to our knowledge, the largest study of the relationship of measures of body habitus and CVD risk among African American adults. Second, this study included well-validated measures of traditional CVD risk factors. Finally, our sample size allowed us to assess these relationships across various demographic characteristics, as well as aggregate CVD risk factors to determine the association of body habitus with Bclusters^of risk factors.
Despite these strengths, there are several limitations to this analysis. First, we assessed the body habitus/CVD risk factor relationship using cross-sectional data, so we are unable to assign causality to these observed relationships. We also did not examine the relationship between these measures of body habitus and CVD events. This study only included African Americans, so we are not able to make comparisons within this study to other racial/ethnic groups. Finally, the JHS only included an assessment of central adiposity with a measure of central adiposity by measuring the circumference at the point of the umbilicus.
In summary, this study provides evidence that measures of central adiposity, particularly WHtR, may be more appropriate for assessing CVD risk in African American adults. Given the simple public health message that your waist should be no more than half your height [19, 22] , WHtR potentially provides an easy-to-use screening tool for the assessment of CVD risk in a clinical setting. However, this approach does come with some potential challenges for clinical adoption. Unlike height and weight, waist circumference is not routinely Bottom row for each characteristic was used as the reference group *P < 0.05 measured at the clinical encounter. There are various measure points used for waist circumference, and some degree of training would have to be provided for clinic for accurately measuring waist circumference, which would lend itself to a lack of specificity among patients. Finally, measuring waist circumference could be challenging in clinical settings given that some undressing of the patient is necessary, and patients with mobility challenges might not be able to stand steady to have their waist measured. This could potentially disrupt clinic flow. There would also need to be some consistent standards as to what circumstances a waist circumference should be measured (e.g., every visit, only well visits). Further research is needed to assess the longitudinal risk for cardiovascular outcomes associated with measures of central adiposity in this population. A recent analysis of longitudinal data from the Women's Health Initiative [23] indicate that WHtR performed as well or better than other measures of body habitus in predicting longitudinal change in CVD risk factors in postmenopausal women. Further research is also needed to determine measuring waist circumference could be readily implemented in traditional clinical settings and whether patients would be receptive to information about their WHtR. Finally, as noted by Katzmarzyk [20] , further research is needed to better understand the biological mechanisms associated with variations in CVD risk across various ethnic groups.
